Pro-con: antiobesity drugs such as glucagon-like peptide-1 receptor agonists should be a first-line treatment in idiopathic intracranial hypertension
Lange, Maria G Vickers, Aroucha Hill, Lisa J Mollan, Susan P Mitchell, James Sinclair, Alexandra J Lee, Andrew G
Lange, Maria G
Vickers, Aroucha
Hill, Lisa J
Mollan, Susan P
Mitchell, James
Sinclair, Alexandra J
Lee, Andrew G
Abstract
No abstract available
MIDER Authors
Affiliations
University of Birmingham; Valley Hospital Medical Center; Las Vegas Neurology Center; University Hospitals Birmingham NHS Foundation Trust; Houston Methodist Hospital; Baylor College of Medicine; Weill Cornell Medicine; University of Texas MD Anderson Cancer Center; Texas A&M College of Medicine; University of Iowa Hospitals and Clinics
Date
2026-03-01
Type
Article
Collections
Citation
Lange MG, Vickers A, Hill LJ, Mollan SP, Mitchell J, Sinclair AJ, Lee AG. Pro-Con: Antiobesity Drugs Such as Glucagon-Like Peptide-1 Receptor Agonists Should Be a First-Line Treatment in Idiopathic Intracranial Hypertension. J Neuroophthalmol. 2026 Mar 1;46(1):117-127. doi: 10.1097/WNO.0000000000002431.